Advanced search in Research outcomes
Filters
Canada Circulation
Year range
Content Provider (100)
ClearCountry (84)
Filters
Canada Circulation
Year range
Content Provider (100)
ClearCountry (84)
Loading
- publication . Article . 2003Open AccessAuthors:Shirya Rashid; Denny K. Y. Trinh; Kristine D. Uffelman; Jeffrey S. Cohn; Daniel J. Rader; Gary F. Lewis;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
Background— We have shown previously that triglyceride (TG) enrichment of HDL, as occurs in hypertriglyceridemic states, contributes to HDL lowering in humans by enhancing the clearance of HDL apolipoprotein (apo) A-I from the circulation. In the New Zealand White ra...
- publication . Article . 2009Open AccessAuthors:Benoit de Varennes; Rakesh K. Chaturvedi; Surita Sidhu; Annie V. Côté; William Li Pi Shan; Caroline Goyer; Roupen Hatzakorzian; Jean Buithieu; Allan D. Sniderman;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
Background— Management of severe ischemic mitral regurgitation remains difficult with disappointing early and intermediate-term surgical results of valve repair. Methods and Results— Forty-four patients with severe (4+) Carpentier type IIIb ischemic mitral regurg...
- publication . Article . 2018Open AccessAuthors:Yuliya Lytvyn; Petter Bjornstad; Jacob A. Udell; Julie A. Lovshin; David Z.I. Cherney;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
We thank Dr Grocott for his comments on our recent review of sodium-glucose cotransporter-2 (SGLT2) inhibitors in Circulation .1 We fully agree that, although rare, there is a potential increased risk for the development of serious adverse effects with SGLT2 inhibitors ...
- publication . Article . 2013Open AccessAuthors:Paul W. Armstrong; Cynthia M. Westerhout;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
There is widespread recognition of the increasing challenge of conducting adequately powered clinical trials in cardiovascular medicine.1 Given the broadening gap between guideline-based recommendations and the level of evidence supported by trials, this matter is a cen...
- publication . Article . 1993Open AccessAuthors:Ruzicka, M; Yuan, B; Harmsen, E; Leenen, F H;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
BACKGROUND The degree of cardiac hypertrophy is not only load dependent: Among other factors, the renin-angiotensin system may play a role in the regulation of cardiac myocyte growth. METHODS AND RESULTS To evaluate the role of the renin-angiotensin system in volume ...
- publication . Article . 2021Open AccessAuthors:Isabelle Johansson; Philip Joseph; Kumar Balasubramanian; John J.V. McMurray; Lars H. Lund; Justin A. Ezekowitz; Deepak Y. Kamath; Khalid F. AlHabib; Antoni Bayes-Genis; Andrzej Budaj; ...Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
Background: Poor health-related quality of life (HRQL) is common in heart failure (HF), but there are few data on HRQL in HF and the association between HRQL and mortality outside Western countries. Methods: We used the Kansas City Cardiomyopathy Questionnaire–12 (KCCQ-...
- publication . Article . 2009Open AccessAuthors:Bouchardy, Judith; Therrien, Judith; Pilote, Louise; Ionescu-Ittu, Raluca; Martucci, Giuseppe; Bottega, Natalie; Marelli, Ariane J.;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
Background— Atrial arrhythmias increase disease burden in the general adult population. Adults with congenital heart lesions constitute a rapidly growing group of patients with cardiovascular disease. We hypothesized that atrial arrhythmias increase with age and impa...
- publication . Article . 2017Open AccessAuthors:Andrés Ricardo Pérez-Riera; Raimundo Barbosa-Barros; Rodrigo Daminello-Raimundo; Luiz Carlos de Abreu; Adrian Baranchuk;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
The patient is a 65-year-old white male with history of type 2 diabetes mellitus, hypertension, chronic smoking, and prior stroke with residual left hemiparesis and aphasia. His medication included losartan, furosemide, simvastatin, and metformin. He was admitted to the...
- publication . Article . 2005Open AccessAuthors:Fayez Bokhari; David Newman; Mary Greene; Victoria Korley; Iqwal Mangat; Paul Dorian;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
Background— The implantable cardioverter defibrillator (ICD) is superior to amiodarone for secondary prophylaxis of sudden cardiac death. However, the magnitude of this benefit over long-term follow-up is not known. Thus, our objective was to evaluate the long-term c...
- publication . Article . 2000Open AccessAuthors:Danshi Li; Agnès Bénardeau; Stanley Nattel;Persistent IdentifiersPublisher: Ovid Technologies (Wolters Kluwer Health)
Background —Rapid atrial pacing (RAP) and congestive heart failure (CHF) produce different experimental substrates for atrial fibrillation (AF). We tested the hypothesis that AF maintained by different substrates responds differently to antiarrhythmic-drug therapy. M...